Work

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19

Year: 2011

Type: article

Abstract: This PharmGKB summary briefly discusses the CYP2C19 gene and current understanding of its function, regulation, and pharmacogenomic relevance.

Source: Pharmacogenetics and Genomics

DOI: 10.1097/fpc.0b013e32834d4962

Authors: Stuart A. Scott, Katrin Sangkuhl, Alan R. Shuldiner, Jean-Sébastien Hulot, Caroline F. Thorn, Russ B. Altman, Teri E. Klein

Institutions: University of Montana, Icahn School of Medicine at Mount Sinai, United States Department of Veterans Affairs, Baltimore VA Medical Center, Stanford University, Inserm, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Génétique, pharmacologie et physiopathologie des maladies cardiovasculaires, Stanford Medicine

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Center for Research Resources

Awards: Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study, PharmGKB: pharmacogenomics knowledge for precision medicine, Mount Sinai Institutes for Clinical and Translational Sciences

OpenAlex ID: W2025995483

FWCI: 6.375

Cites: 417

Cited by: 270

Related to: 10